Northcape Capital Pty Ltd Has $333,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Northcape Capital Pty Ltd lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 638 shares of the medical equipment provider’s stock after selling 481 shares during the quarter. Northcape Capital Pty Ltd’s holdings in Intuitive Surgical were worth $333,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mirador Capital Partners LP raised its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. Exome Asset Management LLC raised its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Consolidated Planning Corp boosted its position in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after buying an additional 76,649 shares in the last quarter. Finally, Swiss National Bank raised its position in Intuitive Surgical by 0.3% in the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after buying an additional 3,400 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of analyst reports. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Royal Bank of Canada lifted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Truist Financial boosted their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $531.88 on Wednesday. The stock has a fifty day moving average of $533.70 and a 200-day moving average of $492.90. The stock has a market cap of $189.44 billion, a PE ratio of 85.51, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $324.12 and a fifty-two week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.